Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Rating) saw a large growth in short interest in the month of September. As of September 15th, there was short interest totalling 66,600 shares, a growth of 26.1% from the August 31st total of 52,800 shares. Based on an average daily volume of 52,000 shares, the days-to-cover ratio is […]